Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19845102 | 0.83 | TSHR (0.46) | TSHRCES1CYP3A4ADRB2ADRB1 | |
| SCHEMBL4492563 | 0.83 | TSHR (0.46) | TSHRCES1CYP3A4ADRB2ADRB1 | |
| SCHEMBL12243060 | 0.83 | TSHR (0.39) | TSHRCES1CYP3A4MEN1THRB | |
| SCHEMBL4986813 | 0.82 | HSD17B10 (0.36) | CES1LMNATDP1 | |
| SCHEMBL18518769 | 0.82 | TSHR (0.37) | TSHRCES1CYP3A4ADRB2ADRB1 | |
| SCHEMBL22423377 | 0.82 | TSHR (0.37) | TSHRCES1CYP3A4ADRB2ADRB1 | |
| SCHEMBL13201999 | 0.80 | CES1 (0.52) | TSHRCES1MEN1THRBHTT | |
| SCHEMBL12962243 | 0.80 | CES1 (0.52) | TSHRCES1MEN1THRBHTT | |
| SCHEMBL12243062 | 0.80 | TSHR (0.41) | TSHRCES1CYP3A4MEN1THRB | |
| SCHEMBL22871752 | 0.80 | TSHR (0.40) | TSHRCES1CYP3A4ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180036689-A1 | FUNCTIONAL POLYMER MEMBRANE, METHOD FOR MANUFACTURING SAME, COMPOSITION FOR FORMING FUNCTIONAL POLYMER MEMBRANE, SEPARATION MEMBRANE MODULE, AND ION-EXCHANGE DEVICE | FUJIFILM CORPORATION (JP) | 2018-02-08 | — | — | US | disclosed |
| US-7368516-B2 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | TOSOH CORPORATION (JP) | 2008-05-06 | — | — | US | disclosed |
| US-20050187419-A1 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | TOSOH CORPORATION (JP) | 2005-08-25 | — | — | US | disclosed |
| US-6900152-B2 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | TOSOH CORPORATION (JP) | 2005-05-31 | — | — | US | disclosed |
| US-20020035029-A1 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | TOSOH CORPORATION (JP) | 2002-03-21 | — | — | US | disclosed |
| US-6337297-B1 | CHROMIUM CATALYST FOR TRIMERIZATION OF ETHYLENE WITH MULTIDENTATE LIGAND OR HALOGEN, CARBOXY GROUP | TOSOH CORPORATION (JP) | 2002-01-08 | — | — | US | disclosed |
| US-5621144-A | Fluorinated compounds as oxygen transport agents | ISIS INNOVATION LIMITED (GB) | 1997-04-15 | — | — | US | disclosed |
| US-5346921-A | Treatment of inflammation with 15-keto-prostaglandin compounds | R-TECH UENO, LTD. (JP) | 1994-09-13 | — | — | US | disclosed |
| US-5290811-A | Administering as antiischemic or antiedema agent; brain disorders, cognition activators | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) | 1994-03-01 | — | — | US | disclosed |
| EP-0577785-A1 | FLUORINATED COMPOUNDS AS OXYGEN TRANSPORT AGENTS | ISIS INNOVATION LIMITED (GB) | 1994-01-12 | — | — | EP | disclosed |
| US-5256696-A | Increase contraction of cardiac muscle | KABUSHIKIKAISHA UENO SEIYAKU OYO KENKYUJO (JP) | 1993-10-26 | — | — | US | disclosed |
| US-5254588-A | Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds | KABUSHIKIKAISHA UENO SEIYAKU OYO KENKYUJO (JP) | 1993-10-19 | — | — | US | disclosed |
| US-5252605-A | Promotion of wound-healing with 15-keto-prostaglandin compounds | R-TECH UENO LTD. (JP) | 1993-10-12 | — | — | US | disclosed |
| WO-1993011098-A1 | FLUORINATED COMPOUNDS AS OXYGEN TRANSPORT AGENTS | ISIS INNOVATION LIMITED (GB) | 1993-06-10 | — | — | WO | disclosed |
| US-5164415-A | Amylase inhibitor | K.K. UENO SEIYAKU OYO KENKYUJO (JP) | 1992-11-17 | — | — | US | disclosed |
| US-5117042-A | 15-KETO-PROSTAGLANDIN COMPOUND FOR IMPROVEMENT OF ENCEPHALIC FUNCTION | K.K. UENO SEIYAKU OYO KENKYUJO (JP) | 1992-05-26 | — | — | US | disclosed |
| US-5096927-A | Treatment for liver disorders | K.K. UENO SEIYAKU OYO KENKYUJO (JP) | 1992-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187419-A1 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | ACMSD, TAF9, ETV6 | TSHR 2240/4885CES1 1157/4885CYP3A4 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.